Related people
Dr. Angela Knierim
Angela is a member of the Practice Area Patents Technology & Life Sciences and the Industry Group Life Sciences & Healthcare. She advises national and international pharmaceutical and medical device companies on all aspects of health law.
One of her main areas of practice is litigation and dispute resolution of competition law complaints (enforcement and defence) in both drug advertising and medical device law. Another focus of her practice is the review of marketing materials and campaigns in terms of drug advertising law. In addition, she provides regulatory advice with regard to the manufacture, labelling and marketing of medicinal products, medical devices, dietary supplements, cosmetics, biocides and chemicals.
Show full CV
Hide full CV
More
Less
More
Less
Career
| Since 2020 | Senior Associate, Taylor Wessing |
| 2019 – 2020 | Associate, Taylor Wessing |
| 2020 | Lecturer for Regulatory Affairs/Digital Health Management, Aalen University |
| 2017 – 2019 | Associate, a law firm specialized in Life Sciences & Healthcare, Duesseldorf |
Education
| 2017 | Ph.D., University of Heidelberg |
| 2017 | Admitted to the Bar |
| 2016 | Second Bar Examination, Higher Regional Court of Duesseldorf |
| 2014 – 2016 | Legal clerkship, Regional Court of Duesseldorf, a.o. with station in Sydney, Australia |
| 2014 | Scientific Assistant at a law firm specialized in medical criminal law and white collar crime, Duesseldorf |
| 2012 | First Bar Examination, University of Heidelberg |
| 2006 – 2012 | Legal studies, University of Heidelberg |
Publications
Aktuelle Rechtsfragen zu Therapieallergenen, in: PharmR, 12/2012, gemeinsam mit Daniel Tietjen Angaben „schnell“ und „nachhaltig“ sind keine vergleichende Werbung – Anm. zu OLG Hamburg, Urteil vom 17.12.2020 – 3 U 199/19, in: GRUR-Prax 2021, S. 458 Health Apps auf Rezept - Start für digitale Gesundheitsanwendungen, in: Medizinprodukte Journal, 03/2020, S. 207 (gemeinsam mit Dr. Nicolai Wiegand) Patents and approvals – medicines, vaccines and diagnostics for COVID-19, in: European Pharmaceutical Review, 03/2020, p. 24 (with Paul England, Dr. Anja Lunze, Jan Phillip Rektorschek and Alison Dennis) Pharmaceutical Patent Law in Times of Crisis: A Comparative Study Part II, in: European Intellectual Property Review Volume 42, Issue 10, 2020, p. 643 (with David Mulder, Christian Dekoninck, Adrian Toutoungi, Matthew Caskie, Dr. Anja Lunze, Barbora Dubanská und Dr. Agnieszka Sztoldman) Die Erstattungsfähigkeit von Therapieallergenen im Zulassungsverfahren, in: PharmR, 02/2020, S. 61 Kommentierung der §§ 25b, 25c, 37, 83, 83a AMG (gemeinsam mit Dr. Alexander Natz), in: Zuck/Dettling (Hrsg.), Arzneimittelgesetz, 2020 Anmerkung zum Urteil des Bundessozialgerichts vom 30. November 2017, Az.: B 3 KR 3/16 R und zum Urteil des Landessozialgerichts Berlin-Brandenburg vom 22. Februar 2018, Az.: L 1 KR 56/14, in MPR 01/2019 Dissertation: Das Tatbestandsmerkmal „Verlangen“ im Strafrecht. Zugleich ein Beitrag zur Unrechtslehre am Beispiel der Tötung auf Verlangen und des Schwangerschaftsabbruchs nach Konfliktberatung, Duncker & Humblot 06/2018: Kooperation von Versandapotheke mit Internetplattform ist unzulässig – Anm. zu OLG Köln, Urt. v. 22.02.2017 – 6 U 101/16 (gemeinsam mit Dr. Christian Stallberg), in: GRUR-Prax 06/2017, S. 267 BGH: Pflicht zur Angabe von Kontaktdaten des Herstellers durch Händler – Motivkontaktlinsen – Anm. zu BGH, Urt. v. 12.01.2017 – I ZR 258/15, in: GRUR-Prax 03/2017, S. 130 (gemeinsam mit Dr. Christian Stallberg) |
Additional languages
| English |
Latest news & insights
Corporate/M&A & capital markets
Click here to find out more
Taylor Wessing advises Formycon on acquisition of biosimilar assets in strategic partnership with ATHOS
31 March 2022
by multiple authors
Digital health
Click here to find out more
Digital Health 2021
26 January 2021
In-depth analysis
by multiple authors
Patents & innovation
Click here to find out more
Pharmaceutical patent law in times of crisis: A comparative study – Part 2
23 November 2020
Quick read
by multiple authors
Commercial & consumer contracts
Click here to find out more
Is a 'clearing the way' action possible in the UPC?
7 June 2023
Quick read
